Categories
Audio Sources - Full Text Articles

Roivant, Pfizer create unit for inflammatory disease drug

2022-12-01T13:22:03Z

Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration

Roivant Sciences (ROIV.O) and Pfizer Inc (PFE.N) on Thursday announced the creation of a new unit to develop RVT-3101, the drugmakers’ treatment for ulcerative colitis.

WP Radio
WP Radio
OFFLINE LIVE